Captopril: Difference between revisions
From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 2: | Line 2: | ||
===Better Known as: Capoten=== | ===Better Known as: Capoten=== | ||
* Marketed By: Bristol-Myers Squibb<br /> | * Marketed By: Bristol-Myers Squibb<br /> | ||
* Major Indication: Hypertension & Congestive Heart Failure<br /> | * Major Indication: [[Hypertension & Congestive Heart Failure]]<br /> | ||
* Drug Class: [[ACE]] Inhibitor | * Drug Class: [[ACE]] Inhibitor | ||
* Date of FDA Approval (Patent Expiration): 1981 (1996)<br /> | * Date of FDA Approval (Patent Expiration): 1981 (1996)<br /> | ||
